根据一项新研究, 血液中ApoB蛋白质的检测比胆固醇检测更能预测心脏病风险. New study finds blood test for apoB proteins better predicts heart disease risk than cholesterol tests.

一项新的研究表明,与标准的胆固醇测试相比,测量血液中的蛋白质B(apoB)可以更准确地预测心脏病风险。 A new study suggests that measuring apolipoprotein B (apoB) proteins in the blood could more accurately predict heart disease risk compared to standard cholesterol tests. 研究人员分析了来自207 000多名没有心脏病史的英国参与者的血液样本,发现ApoB表明“坏胆固醇”粒子的总数,是一个更好的风险标记。 Analyzing blood samples from over 207,000 UK participants with no history of heart disease, researchers found that apoB, which indicates the total number of "bad cholesterol" particles, is a better risk marker. 这一更准确的检验可能拯救生命,而且已经可以通过商业途径获得,易于实施。 This more accurate test could potentially save lives and is already commercially available and easy to implement.